(Q40643483)

22 September 2017

title

Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell lines (English)

1 reference

22 September 2017

1 reference

13

Robert Zeillinger

0 references

author name string

Nicole Concin

1

1 reference

22 September 2017

Christa Zeillinger

2

1 reference

22 September 2017

Dan Tong

3

1 reference

22 September 2017

Margit Stimpfl

4

1 reference

22 September 2017

Margit König

5

1 reference

22 September 2017

Dieter Printz

6

1 reference

22 September 2017

Felix Stonek

7

1 reference

22 September 2017

Christian Schneeberger

8

1 reference

22 September 2017

Lukas Hefler

9

1 reference

22 September 2017

Christian Kainz

10

1 reference

22 September 2017

Sepp Leodolter

11

1 reference

22 September 2017

Oskar A Haas

12

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

Breast Cancer Research and Treatment

22 September 2017

published in

1 reference

22 September 2017

volume

79

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

37-46

1 reference

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

Molecular basis for heterogeneity of the human p53 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

Detection of TP53 mutation, loss of heterozygosity and DNA content in fine-needle aspirates of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

Cancer. p53, guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

Cell cycle control and cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

Epithelial HBL-100 cell line derived from milk of an apparently healthy woman harbours SV40 genetic information

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

A simple p53 functional assay for screening cell lines, blood, and tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

Quantitative Determination of Gene Expression by Competitive Reverse Transcription–Polymerase Chain Reaction in Degraded RNA Samples

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

Mutations in p53 as potential molecular markers for human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

A p53-dependent mouse spindle checkpoint

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

Abnormal centrosome amplification in the absence of p53.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

Mutations of mitotic checkpoint genes in human cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

Mutation and methylation status of p53 gene promoter in human breast tumours

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

Translational regulation of human p53 gene expression.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023351717408

7 January 2021

Identifiers

DOI

10.1023/A:1023351717408

1 reference

Dimensions Publication ID

22 September 2017

1023140584

0 references

1 reference